Vivo Opportunity, LLC, 10% Owner at Terns Pharmaceuticals, Inc. (TERN), sold 724,806 shares at $6.65 ($4.9M) on 2024-04-02, disclosed to the SEC on 2024-04-03.
Scheduled sale ($4.9M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.99 | 5,451 | $38K | 0.8% |
| 2 | $6.99 | 39,411 | $275K | 5.7% |
| 3 | $6.99 | 39,411 | $275K | 5.7% |
| 4 | $6.99 | 136,255 | $952K | 19.6% |
| 5 | $6.99 | 136,255 | $952K | 19.6% |
| 6 | $6.65 | 3,050 |
| $20K |
| 0.4% |
| 7 | $6.65 | 22,084 | $147K | 3.0% |
| 8 | $6.65 | 22,084 | $147K | 3.0% |
| 9 | $6.65 | 76,346 | $508K | 10.4% |
| 10 | $6.65 | 76,346 | $508K | 10.4% |
| 11 | $6.20 | 4,149 | $26K | 0.5% |
| 12 | $6.20 | 30,047 | $186K | 3.8% |
| 13 | $6.20 | 30,047 | $186K | 3.8% |
| 14 | $6.20 | 103,870 | $644K | 13.2% |
| Total | $6.71 avg | 724,806 | $4.9M | 100% |
| Filing → |
| INM | BUY | 2026-06-10 | $392K | — | Filing → |
| SLNO | SELL | 2024-08-29 | $49.2M | — | Filing → |
| TERN | BUY | 2022-09-08 | $2.2M | — | Filing → |